News

November 11, 2015

Block & Leviton LLP Announces That It Has Filed A Class Action Lawsuit Against Checkpoint Systems, Inc. For Violations Of The Federal Securities Laws

BOSTON, November 11, 2015 – Block & Leviton LLP (www.blockesq.com) has filed a class action lawsuit against Checkpoint Systems Inc. (“Checkpoint” or the “Company”) (NYSE:  CKP) and three of the Company’s current or former officers following the Company’s restatement of previously issued financial statements, resulting in a dramatic drop in the Company’s stock price, costing shareholders tens of millions in losses. The case is pending in the United States District… read more

October 22, 2015

Zafgen, Inc. and Its CEO Sued for Securities Fraud

BOSTON, October 21, 2015 /PRNewswire/ — Zafgen, Inc. (“Zafgen” or the “Company”) (NASDAQ: ZFGN) and its chief executive officer, Thomas E. Hughes, were named as defendants in a lawsuit filed by Block & Leviton LLP alleging that they violated the Federal Securities Laws. The lawsuit, filed in Federal Court in the District of Massachusetts, docket number 1:15-cv-13618, alleges that Defendants made misleading misrepresentations about thrombotic adverse events in previous clinical trials… read more

October 15, 2015

Block & Leviton LLP Files Class Action Lawsuit Against EMC’s Board of Directors Alleging Breaches of Fiduciary Duty Regarding EMC’s Proposed Sale To Dell

BOSTON:  Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, has filed a class action lawsuit on behalf of the pension fund for IBEW Local No. 129. The lawsuit claims that the Board of Directors of EMC (“EMC” or the “Company”) (NASDAQ: EMC) breached its fiduciary duties to shareholders with regard to the Company’s proposed sale to Dell Inc. (“Dell”). IBEW Local No. 129 is a significant… read more

October 14, 2015

Block & Leviton Sues Amicus Therapeutics, Inc. Alleging Securities Fraud Over The Company’s Failure To File Its Pre-New Drug Application This Year

BOSTON, October 7, 2015 /PRNewswire/ — Amicus Therapeutics, Inc. (“Amicus” or the “Company”) (NASDAQ: FOLD) and its chief executive officer, John F. Crowley, were named as defendants in a lawsuit alleging that they violated the Federal Securities Laws filed by Block & Leviton LLP. The lawsuit, filed in Federal Court in the District of New Jersey, Lifestyle Investments, LLC v. Amicus Therapeutics, Inc., alleges that defendants issued a press release on… read more

September 21, 2015

Block & Leviton LLP Files Securities Class Action Against Marvell Technology Group Ltd.

BOSTON – Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, has filed a lawsuit in the Southern District of New York on behalf of those who purchased or otherwise acquired Marvell Technology Group, Ltd., (“Marvell” or the “Company”) (Nasdaq: MRVL) securities between November 20, 2014 and September 10, 2015, inclusive (the “Class Period”) against Marvell and certain Directors.  The case is captioned Farno v. Marvell Technology… read more

Block & Leviton LLP
155 Federal Street, Suite 400
Boston, MA 02110
  • Mon 9am - 6pm
  • Tues 9am - 6pm
  • Wed 9am - 6pm
  • Thurs 9am - 6pm
  • Fri 9am - 6pm
  • Sat Closed
  • Sun Closed
Powered by RooSites